<DOC>
	<DOCNO>NCT01585974</DOCNO>
	<brief_summary>This study prospective , non-interventional , non-controlled , multi-center , observational cohort study . The medication prescribe within regular practice physician . Duration dosage treatment solely discretion attend physician . The primary objective study assess duration treatment Turkish renal cell carcinoma patient treat TKIs ( Tyrosine Kinase Inhibitors ) could tolerate prior cytokine treatment within first month treatment .</brief_summary>
	<brief_title>Duration Treatment With Tyrosine Kinase Inhibitors Treatment Metastatic Renal Cell Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<criteria>To diagnose metastatic renal cell carcinoma Previous cytokine therapy To sign informed consent form ( ICF ) Patients willing sign inform consent form withdraw consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Renal Cell Carcinoma</keyword>
	<keyword>TKI</keyword>
	<keyword>Turkey</keyword>
	<keyword>Observational</keyword>
</DOC>